ESR5: Crosslinking cytotoxic T cells and cancer cells with lectins to mediate cell death

Location: University of Freiburg, DE

Supervisor Prof Winfried Römer

As an Early Stage Researcher in Freiburg, you will develop and apply lectins to crosslink T cells and cancer cells leading to cancer cell death. The aim of this project is to investigate the impact of natural and synthetic lectins as cellular crosslinkers. In the framework of this PhD project, the ESR will study the signalling and killing activity of cytotoxic T cells. Through this interdisciplinary project you will develop skills in cell biology, immunology, glycobiology, biochemistry, and become expert in methods like flow cytometry, advanced fluorescence microscopy, ELISA, Western Blots. Appropriate training will be provided in all areas that are new to the researcher.

Applicants should meet the following eligibility criteria:

  • Have a Diploma and/or a Master Degree in Biology, Immunology, and Biochemistry.
  • Experience in mammalian cell culture and fluorescence microscopy is highly appreciated.
  • Have less than 4 years research experience at the signature of the contract (measured from the time the Master’s degree has been obtained).
  • Not have a PhD already.
  • Not have resided or carried out main activity in Germany for more than 12 months in the last 3 years immediately prior to the reference recruitment date.
  • Excellent knowledge of the English language (spoken and written / proficiency level)

The ESR will be contractually employed by Albert-Ludwigs-University Freiburg and will receive a Monthly Living Allowance plus a Mobility Allowance compliant with the applicable EC Marie Skłodowska-Curie Actions-ITN general conditions.

 Application procedure:

Candidates should submit a CV, cover letter and the names and contact details of at least 2 references and transcripts of your university record by e-mail to winfried.roemer@bioss.uni-freiburg.de indicating reference ESR5 in the subject.

The deadline for application is 07/01/2019.Back to: